GEN News Highlights

Sartorius Stedim Biotech (SSB) obtained exclusive global marketing and distribution rights to Aber Instruments’ single-use sensor technology for the biopharmaceutical market. Aber will supply SSB with measuring instruments. SSB will manufacture the biomass sensors under a license, integrate these into its single-use bioreactors, and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

SSB has continuously expanded its process analytics portfolio over the past years in the area of single-use sensors to enable real-time, noninvasive measurement of critical process parameters such as pH, dissolved oxygen content, temperature, glucose, lactate, and biomass.

“Single-use sensors make our disposable bags even more intelligent,” explained Stefan Schlack, senior vp of marketing at SSB. “They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them—a decisive competitive advantage.”

In-line biomass sensors enable precise and reproducible information to be obtained on the progress of a fermentation process without having to take samples and analyze these in the laboratory, continued Schlack.

“As a result, cells are not unnecessarily exposed to stress caused by manual sampling and contamination risks are eliminated. In conjunction with SSB’s existing PAT and software solutions, biomass sensors represent high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes, as well as for further accelerating development times,” he noted.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

41.2%

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

23.5%

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.